Epilepsy in inborn errors of metabolism

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 533-541

  Bahi buisson, Nadia ^a   Dulac, Olivier ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876800819     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00056-7     Document Type: Chapter

References (64)

1. Aicardi J. Epileptic encephalopathies of early childhood. Curr Opin Neurol Neurosurg 1992, 5:344-348.
2. Arrigoni-Martelli E., Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp Clin Res 2001, 27:27-49.
3. Bahi-Buisson N., Kaminska A., Nabbout R., et al. Epilepsy in Menkes disease: analysis of clinical stages. Epilepsia 2006, 47:380-386.
4. Bahi-Buisson N., El Sabbagh S., Soufflet C., et al. Myoclonic absence epilepsy with photosensitivity and a gain of function mutation in glutamate dehydrogenase. Seizure 2008, 17:658-664.
5. Balslev T., Cortez M.A., Blaser S.I., et al. Recurrent seizures in metachromatic leukodystrophy. Pediatr Neurol 1997, 17:150-154.
6. Barkovich A.J., Ali F.A., Rowley H.A., et al. Imaging patterns of neonatal hypoglycemia. AJNR 1998, 19:523-528.
7. Barnerias C., Saudubray J.M., Touati G., et al. Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 2010, 52:e1-e9.
8. Baxter P. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK. Arch Dis Child 1999, 81:431-433.
9. Ben-Ari Y., Gaiarsa J.L., Tyzio R., et al. GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007, 87:1215-1284.
10. Bostantjopoulou S., Katsarou Z., Michelakaki H., et al. Seizures as a presenting feature of late onset metachromatic leukodystrophy. Acta Neurol Scand 2000, 102:192-195.
11. Boyd S.G., Harden A., Egger J., et al. Progressive neuronal degeneration of childhood with liver disease (" Alpers' disease" ): characteristic neurophysiological features. Neuropediatrics 1986, 17:75-80.
12. Campeau P.M., Valayannopoulos V., Touati G., et al. Management of West syndrome in a patient with methylmalonic aciduria. J Child Neurol 2010, 25:94-97.
13. Clayton P.T., Surtees R.A., DeVile C., et al. Neonatal epileptic encephalopathy. Lancet 2003, 361:1614.
14. Chauvel P., Liegeois-Chauvel C., Marquis P., et al. Distinction between the myoclonus-related potential and the epileptic spike in epilepsia partialis continua. Electroencephalogr Clin Neurophysiol 1986, 64:304-307.
15. Christiaens F.J., Mewasingh L.D., Christophe C., et al. Unilateral cortical necrosis following status epilepticus with hypoglycemia. Brain Dev 2003, 25:107-112.
16. Chugani H.T., Shewmon D.A., Sankar R., et al. Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography. Ann Neurol 1992, 31:212-219.
17. Colamaria V., Burlina A.B., Gaburro D., et al. Biotin-responsive infantile encephalopathy: EEG-polygraphic study of a case. Epilepsia 1989, 30:573-578.
18. Collins J.E., Nicholson N.S., Dalton N., et al. Biotinidase deficiency: early neurological presentation. Dev Med Child Neurol 1994, 36:268-270.
19. Dalla Bernardina B., Aicardi J., Goutieres F., et al. Glycine encephalopathy. Neuropadiatrie 1979, 10:209-225.
20. Dalla Bernardina B., Dulac O., Fejerman N., et al. Early myoclonic epileptic encephalopathy (E.M.E.E.). Eur J Pediatr 1983, 140:248-252.
21. Dehan M., Gabilan J.C., Navelet Y., et al. Fifth day fits. Arch Dis Child 1982, 57:400-401.
22. de Koning T.J., Poll-The B.T., Jaeken J. Continuing education in neurometabolic disorders-serine deficiency disorders. Neuropediatrics 1999, 30:1-4.
23. de Koning T.J., Klomp L.W., van Oppen A.C., et al. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 2004, 364:2221-2222.
24. de Meirleir L., Lissens W., Denis R., et al. Pyruvate dehydrogenase deficiency: clinical and biochemical diagnosis. Pediatr Neurol 1993, 9:216-220.
25. Dealberto M.J. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol 2007, 22:330-337.
26. Demarque M., Villeneuve N., Manent J.B., et al. Glutamate transporters prevent the generation of seizures in the developing rat neocortex. J Neurosci 2004, 24:3289-3294.
27. Desguerre I., Pinton F., Nabbout R., et al. Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 2003, 34:265-269.
28. DiMauro S., Hirano M., Kaufmann P., et al. Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol 2002, 89:217-229.
29. Dulac O., Plouin P., Shewmon A. Myoclonus and epilepsy in childhood: 1996 Royaumont meeting. Epilepsy Res 1998, 30:91-106.
30. El Sabbagh S., Lebre A.S., Bahi-Buisson N., et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010, 51:1225-1235.
31. Farrant R.D., Walker V., Mills G.A., et al. Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid: increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem 2001, 276:15107-15116.
32. Ferrari G., Lamantea E., Donati A., et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 2005, 128:723-731.
33. Gallagher R.C., Van Hove J.L., Scharer G., et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann Neurol 2009, 65:550-556.
34. Ganesan V., Johnson A., Connelly A., et al. Guanidinoacetate methyltransferase deficiency: new clinical features. Pediatr Neurol 1997, 17:155-157.
35. Genton P., Malafosse A., Moulard B., et al. Progressive Myoclonus Epilepsies. Epileptic syndromes in Infancy, Childhood, and adolescence 2005, 441-465. John Libbey & Company Ltd, London, Chapter 28. 4th edn. J. Roger, M. Bureau, C. Dravet (Eds.).
36. Gudiño M.A., Campistol J., Chavez B., et al. Hurler's syndrome, West's syndrome, and vitamin D-dependent rickets. J Child Neurol 2002, 17:149-151.
37. Hyland K., Buist N.R., Powell B.R., et al. Folinic acid responsive seizures: a new syndrome?. J Inherit Metab Dis 1995, 18:177-181.
38. Jaeken J., Detheux M., Van Maldergem L., et al. 3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. Arch Dis Child 1996, 74:542-545.
39. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325:529-531.
40. Katayama Y., Maeda K., Iizuka T., et al. Accumulation of oxidative stress around the stroke-like lesions of MELAS patients. Mitochondrion 2009, 9:306-313.
41. Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 2008, 49:46-49.
42. Kossak B.D., Schmidt-Sommerfeld E., Schoeller D.A., et al. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology 1993, 43:2362-2368.
43. Leary L.D., Wang D., Nordli D.R., et al. Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 2003, 44:701-707.
44. Lee Y.M., Kang H.C., Lee J.S., et al. Mitochondrial respiratory chain defects: underlying etiology in various epileptic conditions. Epilepsia 2008, 49:685-690.
45. Mercimek-Mahmutoglu S., Stoeckler-Ipsiroglu S., Adami A., et al. GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 2006, 67:480-484.
46. Mikaeloff Y., Plouin P., Dhondt J.L., et al. Clinical and EEG video-polygraphic features of epileptic spasms in a child with dihydropteridine reductase deficiency. Efficiency of hydrocortisone. Epileptic Disord 2000, 2:213-217.
47. Milh M., Becq H., Villeneuve N., et al. Inhibition of glutamate transporters results in a " suppression-burst" pattern and partial seizures in the newborn rat. Epilepsia 2007, 48:169-174.
48. Mills P.B., Surtees R.A., Champion M.P., et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum Mol Genet 2005, 14:1077-1086.
49. Molinari F., Raas-Rothschild A., Rio M., et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 2005, 76:334-339.
50. Mollet J., Delahodde A., Serre V., et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 2008, 82:623-630.
51. Nabbout R., Soufflet C., Plouin P., et al. Pyridoxine dependent epilepsy: a suggestive electroclinical pattern. Arch Dis Child Fetal Neonatal Ed 1999, 81:F125-F129.
52. Nicolai J., van Kranen-Mastenbroek V.H., Wevers R.A., et al. Folinic acid-responsive seizures initially responsive to pyridoxine. Pediatr Neurol 2006, 34:164-167.
53. Nguyen K.V., Ostergaard E., Ravn S.H., et al. POLG mutations in Alpers syndrome. Neurology 2005, 65:1493-1495.
54. Roger J., Bureau M., Dravet C., et al. Epileptic Syndromes in Infancy, Childhood and Adolescence 1992, John Libbey, London.
55. Salbert B.A., Pellock J.M., Wolf B. Characterization of seizures associated with biotinidase deficiency. Neurology 1993, 43:1351-1355.
56. Santucci M., Ambrosetto G., Scaduto M.C., et al. Ictal and nonictal paroxysmal events in infantile neuroaxonal dystrophy: polygraphic study of a case. Epilepsia 2001, 42:1074-1077.
57. Saudubray J.M., van des Berghe G., Walter J.H. Inborn Metabolic Diseases 2006, Springer, Heidelberg. 4th edn.
58. Schomer D.L. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia 1993, 34:S29-S36.
59. Tassinari C.A., Bureau-Paillas M., Dalla Bernardina B., et al. Lafora disease (author's transl). Rev Electroencephalogr Neurophysiol Clin 1978, 8:107-122.
60. Thakur V., Rupar C.A., Ramsay D.A., et al. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid. Pediatr Crit Care Med 2006, 7:273-276.
61. Wang C., Melberg A., Weis J., et al. The earliest MR imaging and proton MR spectroscopy abnormalities in adult-onset Krabbe disease. Acta Neurol Scand 2007, 116:268-272.
62. Wolf N.I., Rahman S., Schmitt B., et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009, 50:1596-1607.
63. Zgorzalewicz-Stachowiak M., Stradomska T.J., Bartkowiak Z., et al. Cerebral childhood and adolescent X-linked adrenoleukodystrophy: clinical presentation, neurophysiological, neuroimaging and biochemical investigations. Folia Neuropathol 2006, 44:319-326.
64. Zhongshu Z., Weiming Y., Yukio F., et al. Clinical analysis of West syndrome associated with phenylketonuria. Brain Dev 2001, 23:552-557.